Sutton Wealth Advisors’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-74
Closed -$12.3K 1255
2022
Q4
$12.3K Buy
74
+71
+2,367% +$11.1K ﹤0.01% 866
2022
Q3
$422 Buy
3
+2
+200% +$365 ﹤0.01% 1486
2022
Q2
$204 Sell
1
-85
-99% -$18.6K ﹤0.01% 1574
2022
Q1
$21.9K Sell
86
-1
-1% -$272 0.01% 682
2021
Q4
$28.5K Buy
87
+1
+1% +$314 0.01% 600
2021
Q3
$26K Hold
86
0.01% 615
2021
Q2
$23.3K Buy
86
+49
+132% +$12.4K 0.01% 657
2021
Q1
$9.01K Buy
37
+15
+68% +$4.13K ﹤0.01% 912
2020
Q4
$6.31K Hold
22
﹤0.01% 934
2020
Q3
$5.61K Hold
22
﹤0.01% 891
2020
Q2
$4.77K Sell
22
-20
-48% -$4.61K ﹤0.01% 910
2020
Q1
$9.5K Hold
42
0.01% 664
2019
Q4
$10.5K Hold
42
0.01% 809
2019
Q3
$9.99K Buy
+42
New +$9.71K 0.01% 789

Other funds holding MLAB

Sutton Wealth Advisors's MLAB Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Mesa Laboratories (MLAB) in Q1 2023, closing a stake of 74 shares — an estimated $12.3K sold.

Sutton Wealth Advisors first reported a position in MLAB in Q3 2019 and held it in 14 quarters. The position peaked at $28.5K in Q4 2021. 160 funds tracked by Wall St. Rank hold MLAB as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Mesa Laboratories position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 74 Mesa Laboratories shares in Q1 2023, an estimated $12.3K.
  • Sutton Wealth Advisors first reported a position in Mesa Laboratories in Q3 2019 and held it in 14 quarters.
  • Sutton Wealth Advisors's Mesa Laboratories position peaked at $28.5K in Q4 2021.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.